Additionally, a naturally occurring human Chmp4cT232 polymorphism encoding an amino acid substitution of Chmp4c-alanine 232 to threonine that does not bind to Alix, exhibits impaired abscission delay in cytokinesis with DNA bridges and associates with increased susceptibility to ovarian cancer [13,132]. Here, PDCD6IP is linked to ovarian cancer.